openPR Logo
Press release

Korean Skincare Brand SUPPURU Introduces Plant-Derived PDRN Alternative Sourced From Centella Asiatica

03-13-2026 04:18 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Brand Push
Korean Skincare Brand SUPPURU Introduces Plant-Derived PDRN

A new plant-derived ingredient innovation aims to offer a vegan alternative to salmon-based PDRN commonly used in K-beauty formulations.
Image: https://www.globalnewslines.com/uploads/2026/03/cdcf435eab5f8142d0e15e9a5296e6b8.jpg

Korean skincare brand SUPPURU [https://suppuru.com/] has introduced a plant-derived form of polydeoxyribonucleotide (PDRN) sourced from Centella asiatica, marking the ingredient as a vegan PDRN [https://suppuru.com/products/cica-pdrn-vitalizing-serum] alternative to the salmon-derived PDRN widely used in many K-beauty skincare formulations.

PDRN, short for polydeoxyribonucleotide, has become a prominent ingredient in the global skincare market due to its role in supporting skin barrier repair, improving elasticity and promoting overall skin renewal. Traditionally, the compound used in skincare and aesthetic treatments is derived from salmon DNA, which has raised interest among brands and consumers seeking plant-based or vegan alternatives.

SUPPURU's approach centers on what it describes as Cica-PDRN, a plant-derived compound extracted from Centella asiatica, a botanical ingredient commonly used in Korean skincare for its calming and skin-repairing properties. The company states that the ingredient represents a vegan PDRN alternative introducing a plant-based and cruelty-free alternative to salmon-derived PDRN while remaining compatible with vegan formulations.

According to the company, industry analysts note that the global demand for vegan cosmetics has been increasing in recent years, driven by consumer interest in sustainability, ethical sourcing and plant-based biotechnology. Market research firms estimate the vegan cosmetics sector will continue expanding steadily through the end of the decade, with skincare representing one of the fastest-growing segments.

SUPPURU said the launch aims to address a growing industry focus on PDRN alternatives that reduce reliance on animal-derived ingredients while maintaining the ingredient's functional benefits in skincare formulations.

"PDRN has become one of the most recognized ingredients in modern K-beauty skincare, but most consumers associate it with salmon-derived DNA," said Yu Anya of SUPPURU. "Our goal was to develop a Centella asiatica PDRN [https://suppuru.com/products/cica-pdrn-vitalizing-serum] that provides similar skincare functionality while remaining entirely plant-derived and compatible with vegan formulations."

The ingredient appears in the company's Cica-PDRN Vitalizing Serum, which contains 2 percent Cica-PDRN alongside ingredients commonly used in barrier-repair and anti-aging formulations, including adenosine, madecassoside and Centella asiatica extract. According to the company, the formulation is designed to support skin hydration, calm irritation and improve the appearance of fine lines.

Image: https://www.globalnewslines.com/uploads/2026/03/89ff7a9b105addc7eadd3874af502450.jpg

The introduction of cica PDRN [https://suppuru.com/products/cica-pdrn-vitalizing-serum] also addresses a common misconception in the skincare market, where some formulations combine traditional PDRN with centella extracts. SUPPURU said its ingredient differs from those approaches because the PDRN itself is derived from Centella asiatica , rather than being combined with it.

"Consumers are increasingly interested in understanding how ingredients are sourced," Anya said. "Developing a plant-based vegan PDRN derived from Centella asiatica reflects broader changes happening in biotechnology and skincare ingredient development."

Interest in PDRN-based skincare has grown across Asia and globally, with the ingredient appearing in serums, toners and aesthetic treatments. Its popularity in K-beauty has been tied to claims of improving skin elasticity, strengthening the skin barrier and supporting collagen production.

According to SUPPURU, industry observers say the emergence of plant-derived PDRN alternatives may signal a broader shift within the skincare sector toward biotechnology-driven ingredients that combine traditional botanical extracts with molecular-level formulation techniques.

SUPPURU said it plans to continue exploring plant-derived biotechnology ingredients as the company expands its vegan K-beauty skincare portfolio.

About SUPPURU

SUPPURU is a Korean skincare [https://suppuru.com/] brand focused on vegan formulations that combine botanical ingredients with modern skincare technology. The company develops products designed to support skin barrier health, hydration and overall skin balance.

Based in Seoul and operated by KORU Pharma Co., Ltd., SUPPURU produces cruelty-free skincare products and emphasizes environmentally conscious ingredient sourcing as part of its product development approach.
Media Contact
Company Name: SUPPURU
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=korean-skincare-brand-suppuru-introduces-plantderived-pdrn-alternative-sourced-from-centella-asiatica]
Country: Korea
Website: https://suppuru.com/pages/contact

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Korean Skincare Brand SUPPURU Introduces Plant-Derived PDRN Alternative Sourced From Centella Asiatica here

News-ID: 4423023 • Views:

More Releases from Getnews

Empire Property Buyer, LLC Provides Hudson Valley Homeowners With a Simple, Transparent Alternative to Traditional Home Sales
Empire Property Buyer, LLC Provides Hudson Valley Homeowners With a Simple, Tran …
White Plains, NY - March 12, 2026 - Empire Property Buyer, LLC, a real estate investment company, is helping homeowners across New York's Hudson Valley explore a simpler and more flexible alternative to the traditional home-selling process by connecting sellers with qualified investors prepared to purchase properties in as-is condition. Image: https://www.globalnewslines.com/uploads/2026/03/8f296d4d0fefbea06ca895e6b58c3650.jpg Hansel Sanchez, founder of Empire Property Buyer, LLC, a White Plains-based real estate investment company helping New York homeowners sell
Future Electronics Launches Digital Campaign Featuring TAIYO YUDEN MCAS Series MLCCs for Automotive Applications
Future Electronics Launches Digital Campaign Featuring TAIYO YUDEN MCAS Series M …
Image: https://www.globalnewslines.com/uploads/2026/03/1773333737.jpg Future Electronics, a leading global distributor of electronic components, is pleased to announce the launch of a new digital campaign highlighting the TAIYO YUDEN MCAS Series Multi-Layer Ceramic Capacitors (MLCCs), designed to deliver high reliability and stability across a wide range of automotive applications. Montreal, Canada - March 12, 2026 - Future Electronics, a leading global distributor of electronic components, is pleased to announce the launch of a new digital
Roma Pithadiya, CEO of Affordable Insurance and Financial Services, Featured on FOX Morning Blend, Sharing Strategies for Financial Protection & Long-Term Security
Roma Pithadiya, CEO of Affordable Insurance and Financial Services, Featured on …
Image: https://authoritypresswire.com/wp-content/uploads/2026/02/Roma1-removebg-preview.png Roma Pithadiya, President and CEO of Affordable Insurance and Financial Services (AIFS) , was recently featured on FOX's The Morning Blend [https://www.fox47news.com/entertainment/shows/the-morning-blend/interview-with-roma-pithadiya-of-affordable-insurance-and-financial-services-02-18-26], where she shared practical insights on helping families build financial security through strategic insurance planning, retirement preparation, and long-term wealth protection. As a respected financial professional serving clients across Texas and beyond, Pithadiya has built her practice around one central philosophy: financial security begins with education and informed
What is Dialysis and What Kidney Patients Need to Know?
What is Dialysis and What Kidney Patients Need to Know?
Kidney disease is becoming a serious health concern in the United States, affecting millions of people every year. When the kidneys stop working properly, the body is unable to remove waste, extra fluids, and toxins from the blood. In such cases, doctors often recommend dialysis as a life-support treatment. However, many patients do not fully understand what dialysis is, when it is needed, and what other supportive options are available

All 5 Releases


More Releases for PDRN

Salmon PDRN API Salmon PDRN API Market Poised for Accelerated Growth with a CAGR …
Market Summary - The global market for Salmon PDRN API was estimated to be worth US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031. According to QY Research, a new publication titled "Global Salmon PDRN API Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides an in-depth, data-driven analysis of the
Global Polydeoxyribonudeotide (PDRN) Sales Analysis Report: By Region, Players, …
Global Info Research's report offers key insights into the recent developments in the global Polydeoxyribonudeotide (PDRN) market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included. Our report further provides readers with comprehensive insights and actionable analysis on the market to
Polydeoxyribonucleotide (PDRN) Market Forecast Driven by Tissue Regeneration Dem …
Polydeoxyribonudeotide (PDRN) Market Size The global market for Polydeoxyribonudeotide (PDRN) was valued at US$ 72.1 million in the year 2024 and is projected to reach a revised size of US$ 855 million by 2031, growing at a CAGR of 43.0% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-16G12829/Global_Polydeoxyribonudeotide_PDRN_Market_Research_Report_2023 The polydeoxyribonucleotide (PDRN) market is witnessing a steady surge, propelled by growing interest in advanced regenerative treatments for wound healing, orthopedics, aesthetics, and sports-related injuries. PDRN-a
Global PDRN Market Growth Accelerates with Innovation in Aesthetic Medicine and …
Polydeoxyribonudeotide (PDRN) Market Size The global market for Polydeoxyribonudeotide (PDRN) was valued at US$ 72.1 million in the year 2024 and is projected to reach a revised size of US$ 855 million by 2031, growing at a CAGR of 43.0% during the forecast period. Global key players of Polydeoxyribonudeotide (PDRN) include HTL Biotechnology and ReaLi Tide Biological. The top two players hold a share over 44%. China is the largest market, has a
Polydeoxyribonudeotide (PDRN) Market: Size, Share, Growth, Analysis, Key Players …
Polydeoxyribonudeotide (PDRN) Market Size The global Polydeoxyribonudeotide (PDRN) market is projected to grow from US$ 52 million in 2024 to US$ 444.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 43.0% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-16G12829/Global_Polydeoxyribonudeotide_PDRN_Market_Research_Report_2023 Market Trends for the Polydeoxyribonucleotide (PDRN) Market 1. Rising Demand for Regenerative Medicine One of the primary factors driving the Polydeoxyribonucleotide (PDRN) market is the growing demand for regenerative medicine, especially in the treatment of
Cosmetic Grade Polydeoxyribonudeotide (PDRN) Market Size, Revenue, Insights, Ove …
Cosmetic Grade Polydeoxyribonudeotide (PDRN) market is projected to reach US$ 284.9 million in 2029, increasing from US$ 26 million in 2022, with the CAGR of 43.3% during the period of 2023 to 2029. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-39D14950/Global_Cosmetic_Grade_Polydeoxyribonudeotide_PDRN_Market_Research_Report_2023 PDRN is deoxyribonucleic acid (DNA) product, mainly comes from semen and roe of fish, rapidly repair injured scars. It can promote the collagen synthesis on the cell surface, reverse aging signs. PDRN is the excellent